Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares changing hands.
Resverlogix Stock Up 10.0 %
The stock’s fifty day moving average is C$0.06 and its two-hundred day moving average is C$0.06. The firm has a market capitalization of C$15.23 million, a price-to-earnings ratio of -1.10 and a beta of 0.71.
Resverlogix Company Profile
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Why is the Ex-Dividend Date Significant to Investors?
- Work and Play: Investing in the Rise of Bleisure Travel
- What Are Dividend Challengers?
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
